TRACON Pharmaceuticals, Inc. Stock Split Ratio
TRACON Pharmaceuticals, Inc. had Stock Split Ratio of 5.00% as of 2024-04-08, per its 10-Q filed 2024-08-13.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2024-08-13
- 2024-04-08: Stockholders' Equity Note, Stock Split, Conversion Ratio 5.00%.
- 2015-01-16: Stockholders' Equity Note, Stock Split, Conversion Ratio 25.84%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2024-04-08 | 5.00% 10-Q · filed 2024-08-13 |
| 2015-01-16 | 25.84% 10-K · filed 2016-02-19 |